COLUSSI, Gian Luca
 Distribuzione geografica
Continente #
NA - Nord America 2.589
AS - Asia 1.688
EU - Europa 1.119
SA - Sud America 507
AF - Africa 42
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 5.956
Nazione #
US - Stati Uniti d'America 2.497
SG - Singapore 781
IT - Italia 543
BR - Brasile 416
CN - Cina 332
HK - Hong Kong 232
DE - Germania 141
VN - Vietnam 139
RU - Federazione Russa 60
GB - Regno Unito 57
PL - Polonia 51
ID - Indonesia 48
CA - Canada 45
TR - Turchia 42
UA - Ucraina 41
MX - Messico 39
FR - Francia 36
NL - Olanda 34
SE - Svezia 34
AT - Austria 31
AR - Argentina 28
ES - Italia 22
FI - Finlandia 21
JP - Giappone 21
PE - Perù 21
ZA - Sudafrica 20
IN - India 18
BD - Bangladesh 15
EC - Ecuador 13
IR - Iran 12
CO - Colombia 9
PY - Paraguay 9
BE - Belgio 8
CH - Svizzera 8
KR - Corea 8
KE - Kenya 7
TW - Taiwan 7
AE - Emirati Arabi Uniti 6
CL - Cile 5
EG - Egitto 5
IE - Irlanda 5
IQ - Iraq 5
LT - Lituania 5
MY - Malesia 5
AU - Australia 4
RS - Serbia 4
HU - Ungheria 3
MA - Marocco 3
TT - Trinidad e Tobago 3
VE - Venezuela 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
EU - Europa 2
GH - Ghana 2
IL - Israele 2
JO - Giordania 2
NO - Norvegia 2
NP - Nepal 2
PK - Pakistan 2
PT - Portogallo 2
RO - Romania 2
SA - Arabia Saudita 2
TH - Thailandia 2
UZ - Uzbekistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GR - Grecia 1
GT - Guatemala 1
IS - Islanda 1
JM - Giamaica 1
KI - Kiribati 1
KW - Kuwait 1
KZ - Kazakistan 1
MK - Macedonia 1
ML - Mali 1
MT - Malta 1
NZ - Nuova Zelanda 1
SN - Senegal 1
UY - Uruguay 1
YT - Mayotte 1
Totale 5.956
Città #
Singapore 361
Ashburn 346
Fairfield 314
Santa Clara 230
Hong Kong 218
Houston 154
Beijing 151
Woodbridge 133
Dallas 125
Cambridge 118
Seattle 110
Wilmington 88
Ho Chi Minh City 52
Ann Arbor 46
Los Angeles 45
Ferrara 44
Princeton 40
Gdansk 38
Redwood City 38
Chandler 37
Milan 37
Jakarta 33
Nuremberg 32
Chicago 29
Munich 27
Hefei 26
São Paulo 26
Izmir 25
Hanoi 24
Jacksonville 23
New York 23
Mexico City 21
Lima 19
San Diego 19
Addison 18
Nanjing 17
Brooklyn 16
Johannesburg 16
Moscow 16
Rome 16
Frankfurt am Main 15
Ribeirão Prêto 15
Tokyo 15
Belo Horizonte 14
London 14
Dearborn 13
Rio de Janeiro 13
Boston 12
Casalgrande 12
Vienna 12
Washington 12
Mountain View 11
Stockholm 11
Atlanta 10
Chennai 10
Lappeenranta 10
Phoenix 10
Tampa 10
Warsaw 10
Bari 9
Bologna 9
Salt Lake City 9
San Francisco 9
Trieste 9
Assago 8
Buffalo 8
Falkenstein 8
Fortaleza 8
Haiphong 8
Newtown Square 8
Porto Alegre 8
Salvador 8
Brasília 7
Campinas 7
Falls Church 7
Manchester 7
Montreal 7
Nairobi 7
Curitiba 6
Florence 6
Modena 6
Padova 6
Pittsburgh 6
Redmond 6
Tianjin 6
Turku 6
Denver 5
Edmonton 5
Genoa 5
Groningen 5
Guarulhos 5
Hortolândia 5
Hải Dương 5
Naples 5
Norwalk 5
Pelotas 5
Perugia 5
Pescara 5
Quito 5
Taipei 5
Totale 3.649
Nome #
Pattern of in-hospital changes in drug use in the older people from 2010 to 2016 187
Pain and Frailty in Hospitalized Older Adults 180
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 179
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 166
Inappropriate prescription of benzodiazepines in acutely hospitalized older patients 164
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 161
Antibiotic use and associated factors in a large sample of hospitalised older people 158
Comparison between drug therapy-based comorbidity indices and the Charlson Comorbidity Index for the detection of severe multimorbidity in older subjects 155
Implementation of the frailty index in hospitalized older patients: results from the REPOSI register 154
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 145
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register 141
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 135
Beta-Blocker Use in Older Hospitalized Patients Affected by Heart Failure and Chronic Obstructive Pulmonary Disease: An Italian Survey From the REPOSI Register 134
Use and prescription appropriateness of drugs for peptic ulcer and gastrooesophageal reflux disease in hospitalized older people 132
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 129
Carotid plaque detection improves the predictive value of CHA2DS2-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study 126
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 125
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 125
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 122
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 115
Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia 114
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 113
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 113
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 110
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards 106
Use of Lipid-Lowering Drugs and Associated Outcomes According to Health State Profiles in Hospitalized Older Patients 100
Initiation of Psycholeptic Medication During Hospitalization With Recommendation for Discontinuation After Discharge 100
What changed in the Italian internal medicine and geriatric wards during the lockdown 99
Renal Function, Cardiovascular Diseases, Appropriateness of Drug Prescription and Outcomes in Hospitalized Older Patients 95
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 93
Impact of Diabetes Mellitus and Its Comorbidities on Elderly Patients Hospitalized in Internal Medicine Wards: Data from the RePoSi Registry 91
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 88
Atrial fibrillation management in older hospitalized patients: Evidence of a poor oral anticoagulants prescriptive attitude from the Italian REPOSI registry 86
Plasma lipoprotein(A) levels as determinants of arterial stiffening in hypertension 79
Relation between drug therapy-based comorbidity indices, Charlson's comorbidity index, polypharmacy and mortality in three samples of older adults 78
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: analysis of the REPOSI registry 74
COVID-19 Accelerated Cognitive Decline in Elderly Patients with Pre-Existing Dementia Followed up in an Outpatient Memory Care Facility 57
Effect of Combined Proteinuria and Increased Renal Resistive Index on Chronic Kidney Disease Progression: A Retrospective Longitudinal Study 56
‘Help yourself, so the (circadian) rhythms help you’: Chronobiological insights to promote physical and mental health 55
Polyphenols rich diets and risk of type 2 diabetes 52
Development and Validation of the Acute PNeumonia Early Assessment Score for Safely Discharging Low-Risk SARS-CoV-2-Infected Patients from the Emergency Department 52
Elevated Intrarenal Resistive Index Predicted Faster Renal Function Decline and Long-Term Mortality in Non-Proteinuric Chronic Kidney Disease 51
Effects of antithrombotic agents on ophthalmological outcomes, cardiovascular risk, and mortality in hypertensive patients with retinal vein occlusion: An exploratory retrospective study 49
Prognostic role of malnutrition diagnosed by bioelectrical impedance vector analysis in older adults hospitalized with covid-19 pneumonia: A prospective study 49
Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients 48
Diagnostic role of CD64 expression on neutrophils as biomarker for blood stream infection in liver cirrhosis: some preliminary findings 48
Kidney Disease Management in the Hospital Setting: A Focus on Inappropriate Drug Prescriptions in Older Patients 48
Effects of insomnia and restless legs syndrome on sleep arterial blood pressure: A systematic review and meta-analysis 44
Secondary hyperparathyroidism is associated with postpartum blood pressure in preeclamptic women and normal pregnancies 44
Effect of heparin treatment on pulmonary embolism and in-hospital death in unvaccinated COVID-19 patients without overt deep vein thrombosis 43
Dulaglutide reduces binge episodes in type 2 diabetic patients with binge eating disorder: A pilot study 43
Interactions between vitamin D levels, cardiovascular risk factors, and atherothrombosis markers in patients with symptomatic peripheral artery disease 42
Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge 41
Echocardiographic Comparison of COVID-19 Patients with or without Prior Biochemical Evidence of Cardiac Injury after Recovery 40
Role of MR-proADM and Monocyte CD169 in Predicting In-Hospital and 60-Day Mortality in COVID-19 Patients 38
Aldosterone and Left Ventricular Remodeling 36
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 36
Association of Post-Saline Load Plasma Aldosterone Levels with Left Ventricular Hypertrophy in Primary Hypertension 36
Atrial fibrillation and its complications in arterial hypertension: The potential preventive role of ω-3 polyunsaturated fatty acids 36
Aortic stiffness and indexes of disease severity in subjects with previous COVID-19 penumonia:a follow-up study 35
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 35
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients 34
Benzodiazepines: an old class of new antihypertensive drugs? 34
Effect of intermediate/high versus low dose heparin on the thromboembolic and hemorrhagic risk of unvaccinated COVID-19 patients in the emergency department 33
Relationships between NAFLD biochemical scores and left ventricular geometric pattern in naive essential hypertensive patients 32
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 32
Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment 31
Prognostic scores and early management of septic patients in the emergency department of a secondary hospital: results of a retrospective study 30
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 25
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 25
Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study 24
Hypertension and type 2 diabetes: lights and shadows about causality 22
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 17
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 17
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients 16
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 15
Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3Kγ 15
Glucocorticoid-induced leucine zipper protein regulates sodium and potassium balance in the distal nephron 15
HICCups and inappropriate ADH secretion syndrome as presentations of tick-borne disease 14
Functioning or Non-Functioning Adrenal Adenoma? Probably, Just a Matter of Time 14
Novel role for SGK3 in glucose homeostasis revealed in SGK3/Akt2 double-null mice 13
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 13
Dietary Salt Intake Is a Determinant of Cardiac Changes After Treatment of Primary Aldosteronism: A Prospective Study 13
Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension 12
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 11
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 11
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 11
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 11
Omega-3 polyunsaturated fatty acids decrease plasma lipoprotein(a) levels in hypertensive subjects 11
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 10
Impact of statin therapy on plasma levels of plasminogen activator inhibitor-1: A systematic review and meta-analysis of randomised controlled trials 10
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 10
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 9
Omega-3 Polyunsaturated Fatty Acids in the Treatment of Non-Alcoholic Fatty Liver Disease: Are They So Good? 9
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 8
ω-3 Polyunsaturated Fatty Acids Effects on the Cardiometabolic Syndrome and their Role in Cardiovascular Disease Prevention: An Update from the Recent Literature 8
Microalbuminuria and plasma aldosterone levels in nondiabetic treatment-naive patients with hypertension 7
Totale 6.208
Categoria #
all - tutte 34.916
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.916


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021460 0 0 0 0 80 44 42 70 59 48 86 31
2021/2022633 139 103 30 35 66 41 15 46 24 18 21 95
2022/2023185 39 17 6 17 17 14 28 11 19 4 8 5
2023/2024294 8 7 23 19 16 53 10 8 4 13 55 78
2024/20251.585 30 11 66 12 238 168 126 86 144 270 252 182
2025/20262.031 368 254 566 554 289 0 0 0 0 0 0 0
Totale 6.208